AGP Picks
View all

Samoa Wellness Report
Provided by AGP

Samoa Wellness Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Samoa Wellness Report.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 29, 2026

Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma
Jul. 29, 2026

Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma

Indeterminate GlobeNewswire
CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
Jul. 29, 2026

CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026

Indeterminate GlobeNewswire
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
Jul. 29, 2026

PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀

Indeterminate GlobeNewswire
Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA-Regulated Pharmaceutical Development Program
Jul. 29, 2026

Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA-Regulated Pharmaceutical Development Program

Indeterminate GlobeNewswire
TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages
Jul. 29, 2026

TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages

Indeterminate GlobeNewswire
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
Jul. 29, 2026

FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.

Indeterminate GlobeNewswire
ACTG to Make Three Presentations on HIV Cure and Aging with HIV at AIDS 2026
Jul. 29, 2026

ACTG to Make Three Presentations on HIV Cure and Aging with HIV at AIDS 2026

Indeterminate GlobeNewswire
Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
Jul. 29, 2026

Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston

Indeterminate GlobeNewswire
NewAmsterdam Pharma to Host Investor Day on August 5, 2026
Jul. 29, 2026

NewAmsterdam Pharma to Host Investor Day on August 5, 2026

Indeterminate GlobeNewswire
MediWound to Report Second Quarter 2026 Financial Results
Jul. 29, 2026

MediWound to Report Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
Jul. 29, 2026

UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026

Indeterminate GlobeNewswire
Noom Health partners with Levrx to bring personalized weight management support into the pharmacy benefits experience
Jul. 29, 2026

Noom Health partners with Levrx to bring personalized weight management support into the pharmacy benefits experience

Indeterminate GlobeNewswire
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
Jul. 29, 2026

Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights

Indeterminate GlobeNewswire
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
Jul. 29, 2026

Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Jushi Holdings Provides Update on Plan of Arrangement
Jul. 29, 2026

Jushi Holdings Provides Update on Plan of Arrangement

Indeterminate GlobeNewswire
Realize Medical Appoints Chris Marrus to Board of Directors
Jul. 29, 2026

Realize Medical Appoints Chris Marrus to Board of Directors

Indeterminate GlobeNewswire
PROLLENIUM® Expands PACE with Launch of Eight New Clinical Education Modules
Jul. 29, 2026

PROLLENIUM® Expands PACE with Launch of Eight New Clinical Education Modules

Indeterminate GlobeNewswire
LB Pharmaceuticals Announces $150 Million Private Placement
Jul. 29, 2026

LB Pharmaceuticals Announces $150 Million Private Placement

Indeterminate GlobeNewswire
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
Jul. 29, 2026

Tevogen Bio Holdings Inc. Becomes Tevogen Inc.

Indeterminate GlobeNewswire
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones
Jul. 29, 2026

Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Samoa Wellness Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.